GDTC — CytoMed Therapeutics Ltd

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1873093 ·
Last close
$0.78
Market Cap
$9.27M
52W High
$2.29
52W Low
$0.68
ADV30
14,648
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 7,015,093 1,458,764 1,615,776
Dec 2025 — — — — 7,984,953 2,095,489 1,131,286

Balance + Analyst (yfinance extras)

Retained Earnings
$-20,599,044
Inventory
—
Receivables
$385,152
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$860,848
EBITDA
$-3,849,627
Free Cash Flow
$-2,715,337
Enterprise Value
$7,943,764
Total Cash
$2,095,489
Total Debt
$482,562
Shares Out
11,832,835
Trailing EPS
$-0.27
Book Value
$0.43
ROE
-50.3%
ROA
-29.3%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 324,387 -4,241,678 -3,980,457 7,984,953 1,131,286 6,544,446 -3,697,463
Dec 2024 69,501 -3,130,528 -2,516,698 10,067,749 1,023,960 8,966,040 -2,709,929
Dec 2023 0 -3,842,846 -4,132,896 12,368,870 1,124,715 11,245,111 -3,531,196
Dec 2022 0 -1,856,566 -3,131,209 5,227,058 4,640,760 586,980 -1,398,409
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.15

Peers — same industry

TickerNameMarket CapLastDaily %
CLRB Cellectar Biosciences, Inc. $9.24M $0.92 —
PTN PALATIN TECHNOLOGIES INC $9.55M $5.36 —
PBM PSYENCE BIOMEDICAL LTD. $9.57M $2.51 —
BIVI BIOVIE INC. $9.61M $1.00 —
RADX Radiopharm Theranostics Ltd $9.70M $0.67 —

News headlines (Yahoo Finance, 1h cache)

CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
2026-10-09 20:30 · Yahoo
CytoMed Therapeutics And 2 More Penny Stocks With Promising Prospects
2026-02-06 18:05 · Yahoo
Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress
2026-01-29 15:11 · Yahoo
CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress
2026-01-28 15:00 · Yahoo
CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital
2026-01-13 13:00 · Yahoo
CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogene
2025-12-08 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.